Purpose

The purpose of this study is to test the effectiveness of Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CCAARTT), a novel treatment for active duty service members and veterans to reduce anger and aggression and improve interpersonal functioning after experiencing military-related betrayal. 

Category

IRB Number
20230329HU
NCT Number
-
Open to Enrollment
Sponsor
-



Study Contact

Principal Investigator
Vanessa Jacoby

Regulatory Point of Contact
Anna Gonzalez
210-562-6734
gonzaleza4@uthscsa.edu

Regulatory Point of Contact
Irene Hargita
210-562-6704
hargita@uthscsa.edu



Eligibility

Eligible Ages
-
Eligible Genders
all
Accepts Healthy Volunteers
No

Inclusion Criteria

    Other Inclusion Criteria:

    • Adult active duty military service members and veterans aged 18 or older. 
    • Endorses a history of military-related betrayal (on the Brief Betrayal Trauma Survey; BBTS)
    • Endorses problematic anger in the past month (as evidenced by a score of 12 or above on the Dimensions of Anger Reactions; DAR-5)
    • Engaged in at least 1 self-reported act of aggression in the past 1 month (on the Overt Aggression Scale-Modified; OAS-M)

Exclusion Criteria

    Other Exclusion Criteria:

    • Participated in an anger management or trauma-focused intervention within the past 3 months as assessed by self-report
    • Acute suicidality requiring immediate intervention, such as hospitalization as assessed by the DSI-SS combined with follow up clinical interview for elevated scores.
    • Is currently homicidal with plans and intent to hurt a specific person and requiring immediate intervention as measured by self-report and follow-up with clinician if screened positive.
    • Moderate to severe brain injury as measured by inability to comprehend the informed consent document or baseline assessments
    • Has severe alcohol consumption patterns as evidenced by a score of 19 or above on the Alcohol Use Disorders Identification Test; AUDIT.
    • Experiencing active psychosis or mania as measured by the Prodromal Questionnaire-Brief Version and the Mood Disorders Questionnaire, respectively.